Company: LHI
Filing Date: 2025-05-23
Form Type: F-1
Source: 0001213900-25-046955
Chunk: 94

Company: Living Homeopathy International Ltd.
Filing Date: 2025-05-23
Form: F-1
Chunk 94
---
.

<div align='center'>48

USE OF PROCEEDS</div>

Living Homeopathy estimates that it will receive
net proceeds of $4.13 million from this offering, after deducting the estimated underwriting discounts and the estimated offering expenses
payable by Living Homeopathy and based upon an assumed initial public offering price of $5.00 per Class A Ordinary Share, which is the
midpoint of the price range as set forth on the cover page of this prospectus.

Living Homeopathy plans to use the net proceeds we receive from this offering for the following purposes:

| ● | approximately 40%, or $1.65 million, for advertising planning, including                                                                      
 without limitation, engaging advertising service providers to design advertisement content and place advertisements, and paying advertisement 
 placement fees;                                                                                                                               |

| ● | approximately 30%, or $1.24 million, for market and product development                                                               
 and product marketing, including without limitation, recruiting marketing personnel, engaging third-party marketing service providers 
 to design and implement marketing plans, attending industry forums, and hosting marketing events; and                                 |

| ● | approximately 30%, or $1.24 million for working capital and 
 general corporate purposes.                                 |

The precise amounts and percentage of proceeds we would devote to particular categories of activity will depend on prevailing market and business conditions as well as particular opportunities that may arise from time to time. The above expected use of the net proceeds from this offering represents our intentions based upon our current plans and business conditions, which could change in the future as our plans and business conditions evolve. The amounts and timing of our actual expenditures may vary significantly from the above depending on numerous factors, including any unforeseen cash needs. Similarly, the priority of our prospective uses of proceeds will depend on business and market conditions. Accordingly, our management will have significant flexibility and broad discretion in applying the net proceeds of the offering. If any unforeseen event occurs or the business conditions change, we may use the proceeds of this offering differently from that described in this prospectus. To the extent that the net proceeds we receive from this offering are not immediately used for the above purpose, we intend to invest its net proceeds in short-term, interest-bearing bank deposits or debt instruments.

<div align='center'>49

DETERMINATION OF OFFERING PRICE</div>

Since Living Homeopathy’s Class A Ordinary Shares are not listed or quoted on any exchange or quotation system, the offering price of Living Homeopathy’s Class A Ordinary Shares was determined by Living Homeopathy and the